Multi Cancer Early Detection Market Size, Trends and Insights By Type (Liquid Biopsy, Gene Panel, LDT, Others), By End User (Hospitals, Diagnostic Laboratories, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030


Report Code: CMI18256

Published Date: September 2022

Pages: 220+

Category: Clinical Diagnostics

Reports Description

According to Custom Market Insights (CMI), The Global Multi Cancer Early Detection Market Size was valued at USD 800.23 million in 2021 and is estimated to reach USD 2.89 billion by the end of 2030 at a CAGR of approximately 16.5% during the forecast period 2022-2030.

Multi-cancer early detection is a diagnostic test intended to detect the various types of cancer in the human body.

Multi Cancer Early Detection Market Share

To learn more about this report, 

Multi-cancer early detection test is carried out by taking various samples such as blood, liquid biopsy, gene, LTD, and others. This diagnostic test helps physicians examine the risk of developing the multiplication of cancer cells inside a blood vessel, epidermis, colon, lungs, throat, and other body parts. In response, MCED is intended to find tumors in the body.

Furthermore, several medical device manufacturing companies are coming up with various devices that detect cancer at an early stage. In addition, government support and investment in these sectors are driving the market growth.

Growth Factors

The Growing use of multi-cancer early detection in hospitals and laboratory sectors will aid the market growth.

The multi-cancer early detection market has witnessed a high potential growth due to increased awareness, and government focus on the early detection test has driven the market growth. For instance, WHO supports the Member States in developing and implementing cancer early diagnosis and screening programs, according to assessed feasibility and cost-effectiveness of screening, and with adequate capacity to avoid delays in diagnosis and cancer treatment. The overall demand for the multi-cancer early detection testing market will be expected to grow exponentially.

In response to this, the rise in the number of smoking, drinking, obesity, and elevated cholesterol level, exposure to harmful radiation are the key factors contributing to the death of people every year. For instance, according to an article by WHO in February 2022, cancer deaths accounted for nearly 10 million deaths in 2020, or nearly one in six. These factors are making people more conscious about multi-cancer early detection tests, which have enhanced the potential sales of the market, thus, offering the most lucrative opportunities. 

Multi-cancer early detection Market Segmentation

Multi Cancer Early Detection market, segmented by Type

Depending upon the types, the multi-cancer early detection market is segmented into liquid biopsy, gene panel, LDT, and others.

The gene panel, LDT, and other segments dominated the market in 2021 and are expected to grow with 80% of the total market share over the forecast period. The gene panel segment mainly deals with hereditary cancers where various organizations in developed and developing countries have initiated the multi-cancer early detection test. For instance, an article published by National Cancer Institute (NIH) recommended cancer genetic testing projects, and a clinical trial has been acknowledged. These factors are boosting the overall market growth in the outlook period.

According to an article published by National Cancer Institute, several Companies with MCED tests currently under study claim that they can detect anywhere from two or three cancer types up to as many as 50. These factors capture the market growth during the forecast period.

Furthermore, the liquid biopsy segment is expected to show a significant growth rate during the forecast period. The FDA has approved the

blood test for cancer detection, known as liquid biopsies as a simple and non-invasive alternative to surgical biopsies that enable doctors to discover a range of information about tumors through simple blood sample assays. The multi-cancer early detection device is gaining popularity owing to its efficiency and accuracy with advanced software solutions, which has boosted the market growth in upcoming years.

Multi-cancer early detection market, the segment based on End-User

The global multi-cancer early detection market is studied across hospitals, diagnostic laboratories, and others. It is expected that the global hospital end-user segment to hold a dominant position during 2022 -2031 and accounts for 48% of the total market share.

Hospital’s end-user segment dominates the multi-cancer early detection market and is expected to remain dominant during the forecast period. This is attributed to the fact that specialized physicians and well-trained staff in the treatment procedure are expected to enhance the overall demand for multi-cancer early detection tests. The testing is considered a high-performance, effective device with easy operation, accuracy and quick detection. Owing to these factors multi, early cancer detection has been used extensively in multispecialty and tertiary care hospitals. The multi-cancer early detection devices have captured the overall market share and escalated the demand in the market during the forecast period.

In addition, the growing population worldwide, rising disease, increased R&D activities in cancer institutes, and government and NGO support from developed and developing nations have spurred the overall market growth.

Multi Cancer Early Detection Market (By End User)

To learn more about this report, 

Furthermore, the research and laboratory and diagnostic laboratories segment are expected to create the most lucrative application for the multi-cancer early detection market. The demand for multi-cancer early detection is increasing owing to consumers increasing demand, rapid shift in lifestyle, and increased health consciousness among people making them more linear towards opting for body checks, and early detection multi-cancer tests, among others. In addition, several key companies are offering multi-cancer early detection diagnostic tests in various laboratories at cheap prices compared to hospitals. Furthermore, the increased focus on multi-cancer early detection activities has surged the market growth.

Report Scope

Feature of the Report Details
Market Size in 2021 USD 800.23 million
Projected Market Size in 2030 USD 2.89 billion
CAGR Growth Rate 16.5% CAGR
Base Year 2021
Forecast Period 2022-2030
Prominent Players Grail LLC (Illumina Inc.), Exact Sciences Corporation., Foundation Medicine Inc., AnchorDx, Guardant Healt Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine Inc., Singlera Genomics Inc., and Others
Key Segment By Type, End User, and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Regional Insights

Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Europe is the dominant region in the multi-cancer early detection market and accounts for 30% of the total market share. The utilization of multi-cancer early detection has increased in sectors such as hospitals, laboratories, diagnostic centers, and other key market trends in Europe. The rise in the population, associated with high susceptibility to chronic diseases related to cancer, and economic diagnosis of chronic diseases in rural areas are expected to boost the global market growth in Europe. In addition, Europe’s rising cases have witnessed significant market growth. For instance, according to an article by Eurostat in 2019, among the EU Member States, the highest standardized death rates for cancer were recorded in Hungary and Croatia, each with at least 300 per 100 000 inhabitants. Owing to these factors European Union has initiated and increased focus on multi-cancer early detection programs across the region. These factors are responsible for the market growth in the upcoming years.

Asia-Pacific and North America have shown positive growth in multi cancer early detection market.

The multi-cancer early detection market in the Asia Pacific is expected to experience rapid growth over the forecast period due to the growing population and increasing purchasing power of patients, an increase in the number of tests during a pandemic, and growing awareness of people about good health I have made them more linear towards purchasing or opting for multi cancer early detection market. These factors are projected to enhance the overall demand for the multi-cancer early detection market in the upcoming years.

Moreover, China and Japan are the topmost producers of medical devices in the world where. Multi-cancer early detection testing is widely employed in medical, hospitals, diagnostic centers, and many others due to rising obesity among people, an increase in lung cancer, and an increase in the number of multi-cancer people has increased the potential sales of multi-cancer early detection market.

These factors are escalating the demand for multi-cancer early detection in Asia-Pacific.

Also, the region has well established in the medical sector, where demand for multi-cancer early detection has increased.

Multi Cancer Early Detection Market (trends by region)

To learn more about this report, 

North America is also anticipated to maintain its dominance throughout the forecast period. Countries such as the U.S., Canada, and Mexico have significantly contributed to the region’s multi-cancer early detection market growth.

COVID-19 Analysis

The novel coronavirus is an incomparable global pandemic that has spread to over 180 countries and caused huge losses of lives and the economy around the globe. The guidelines and policies of the logistics and supply chain of the multi-cancer early detection market were affected slightly. In the first quarter of 2020, reductions in cancer diagnosis worldwide have led to concerns over the implications of reduced testing for multi-cancer morbidity and mortality.

In addition, the increase in the number of COVID patients, in turn, leads to more cancer tests. Furthermore, several manufacturers have increased their production capacities for Multi cancer early detection devices to meet the growing demand.

In addition, as the restrictions imposed due to lockdowns are being lifted in the fourth quarter of the pandemic, the healthcare, pharmaceutical, among other sectors is expected to recover soon owing to the record of multi-cancer early detection production units in both developed and developing economies.

Segments covered in the report

Key market segments

By Type

  • Liquid Biopsy
  • Gene Panel
  • LDT
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Others

On the basis of Geography

North America

  • The U.S.
  • Canada
  • Mexico

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Ultrasonic Dissection Devices Market, (2022 – 2030) (USD Million)
    • 2.2 Global Ultrasonic Dissection Devices Market: snapshot
  • Chapter 3. Global Ultrasonic Dissection Devices Market – Industry Analysis
    • 3.1 Ultrasonic Dissection Devices Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Use Of Multi-Cancer Early Detection In Hospitals And Laboratory Sectors
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Type
      • 3.7.2 Market attractiveness analysis By End User
  • Chapter 4. Global Ultrasonic Dissection Devices Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Ultrasonic Dissection Devices Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Ultrasonic Dissection Devices Market – Type Analysis
    • 5.1 Global Ultrasonic Dissection Devices Market overview: By Type
      • 5.1.1 Global Ultrasonic Dissection Devices Market share, By Type, 2021 and 2030
    • 5.2 Liquid Biopsy
      • 5.2.1 Global Ultrasonic Dissection Devices Market by Liquid Biopsy, 2022 – 2030 (USD Million)
    • 5.3 Gene Panel
      • 5.3.1 Global Ultrasonic Dissection Devices Market by Gene Panel, 2022 – 2030 (USD Million)
    • 5.4 LDT
      • 5.4.1 Global Ultrasonic Dissection Devices Market by LDT, 2022 – 2030 (USD Million)
  • Chapter 6. Global Ultrasonic Dissection Devices Market – End User Analysis
    • 6.1 Global Ultrasonic Dissection Devices Market overview: By End User
      • 6.1.1 Global Ultrasonic Dissection Devices Market share, By End User, 2021 and 2030
    • 6.2 Hospitals
      • 6.2.1 Global Ultrasonic Dissection Devices Market by Hospitals, 2022 – 2030 (USD Million)
    • 6.3 Diagnostic Laboratories
      • 6.3.1 Global Ultrasonic Dissection Devices Market by Diagnostic Laboratories, 2022 – 2030 (USD Million)
  • Chapter 7. Ultrasonic Dissection Devices Market – Regional Analysis
    • 7.1 Global Ultrasonic Dissection Devices Market Regional Overview
    • 7.2 Global Ultrasonic Dissection Devices Market Share, by Region, 2021 & 2030 (USD Million)
    • 7.3. North America
      • 7.3.1 North America Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
        • 7.3.1.1 North America Ultrasonic Dissection Devices Market, by Country, 2022 – 2030 (USD Million)
    • 7.4 North America Ultrasonic Dissection Devices Market, by Type, 2022 – 2030
      • 7.4.1 North America Ultrasonic Dissection Devices Market, by Type, 2022 – 2030 (USD Million)
    • 7.5 North America Ultrasonic Dissection Devices Market, by End User, 2022 – 2030
      • 7.5.1 North America Ultrasonic Dissection Devices Market, by End User, 2022 – 2030 (USD Million)
    • 7.6. Europe
      • 7.6.1 Europe Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
        • 7.6.1.1 Europe Ultrasonic Dissection Devices Market, by Country, 2022 – 2030 (USD Million)
    • 7.7 Europe Ultrasonic Dissection Devices Market, by Type, 2022 – 2030
      • 7.7.1 Europe Ultrasonic Dissection Devices Market, by Type, 2022 – 2030 (USD Million)
    • 7.8 Europe Ultrasonic Dissection Devices Market, by End User, 2022 – 2030
      • 7.8.1 Europe Ultrasonic Dissection Devices Market, by End User, 2022 – 2030 (USD Million)
    • 7.9. Asia Pacific
      • 7.9.1 Asia Pacific Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
        • 7.9.1.1 Asia Pacific Ultrasonic Dissection Devices Market, by Country, 2022 – 2030 (USD Million)
    • 7.10 Asia Pacific Ultrasonic Dissection Devices Market, by Type, 2022 – 2030
      • 7.10.1 Asia Pacific Ultrasonic Dissection Devices Market, by Type, 2022 – 2030 (USD Million)
    • 7.11 Asia Pacific Ultrasonic Dissection Devices Market, by End User, 2022 – 2030
      • 7.11.1 Asia Pacific Ultrasonic Dissection Devices Market, by End User, 2022 – 2030 (USD Million)
    • 7.12. Latin America
      • 7.12.1 Latin America Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
        • 7.12.1.1 Latin America Ultrasonic Dissection Devices Market, by Country, 2022 – 2030 (USD Million)
    • 7.13 Latin America Ultrasonic Dissection Devices Market, by Type, 2022 – 2030
      • 7.13.1 Latin America Ultrasonic Dissection Devices Market, by Type, 2022 – 2030 (USD Million)
    • 7.14 Latin America Ultrasonic Dissection Devices Market, by End User, 2022 – 2030
      • 7.14.1 Latin America Ultrasonic Dissection Devices Market, by End User, 2022 – 2030 (USD Million)
    • 7.15. The Middle-East and Africa
      • 7.15.1 The Middle-East and Africa Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
        • 7.15.1.1 The Middle-East and Africa Ultrasonic Dissection Devices Market, by Country, 2022 – 2030 (USD Million)
    • 7.16 The Middle-East and Africa Ultrasonic Dissection Devices Market, by Type, 2022 – 2030
      • 7.16.1 The Middle-East and Africa Ultrasonic Dissection Devices Market, by Type, 2022 – 2030 (USD Million)
    • 7.17 The Middle-East and Africa Ultrasonic Dissection Devices Market, by End User, 2022 – 2030
      • 7.17.1 The Middle-East and Africa Ultrasonic Dissection Devices Market, by End User, 2022 – 2030 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 Grail LLC (Illumina Inc.)
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Exact Sciences Corporation.
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Foundation Medicine Inc.
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 AnchorDx
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Guardant Healt Inc.
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Burning Rock Biotech Limited
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 GENECAST
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Laboratory for Advanced Medicine Inc.
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Singlera Genomics Inc
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments

List Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Ultrasonic Dissection Devices Market attractiveness, By Type
  • 6. Global Ultrasonic Dissection Devices Market attractiveness, By End User
  • 7. Global Ultrasonic Dissection Devices Market share by Type, 2022 and 2030 (USD Million)
  • 8. Global Ultrasonic Dissection Devices Market by Liquid Biopsy, 2022 – 2030 (USD Million)
  • 9. Global Ultrasonic Dissection Devices Market by Gene Panel, 2022 – 2030 (USD Million)
  • 10. Global Ultrasonic Dissection Devices Market by LDT, 2022 – 2030 (USD Million)
  • 11. Global Ultrasonic Dissection Devices Market share by End User, 2022 and 2030 (USD Million)
  • 12. Global Ultrasonic Dissection Devices Market by Hospitals, 2022 – 2030 (USD Million)
  • 13. Global Ultrasonic Dissection Devices Market by Diagnostic Laboratories, 2022 – 2030 (USD Million)
  • 14. Global Ultrasonic Dissection Devices Market share, by Region, 2022 and 2030
  • 15. North America Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
  • 16. Europe Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
  • 17. Asia Pacific Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
  • 18. Latin America Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)
  • 19. The Middle-East and Africa Ultrasonic Dissection Devices Market, 2022 – 2030 (USD Million)

List Of Tables

  • 1. Global Ultrasonic Dissection Devices Market: Snapshot
  • 2. Drivers of the Ultrasonic Dissection Devices Market: impact analysis
  • 3. North America Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 4. North America Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 5. U.S. Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 6. U.S. Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 7. Canada Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 8. Canada Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 9. Europe Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 10. Europe Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 11. Germany Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 12. Germany Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 13. France Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 14. France Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 15. U.K. Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 16. U.K. Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 17. Italy Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 18. Italy Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 19. Spain Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 20. Spain Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 21. Rest of Europe Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 22. Rest of Europe Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 23. Asia Pacific Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 24. Asia Pacific Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 25. China Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 26. China Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 27. Japan Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 28. Japan Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 29. India Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 30. India Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 31. South Korea Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 32. South Korea Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 33. South-East Asia Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 34. South-East Asia Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 35. Rest of Asia Pacific Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 36. Rest of Asia Pacific Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 37. Latin America Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 38. Latin America Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 39. Brazil Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 40. Brazil Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 41. Mexico Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 42. Mexico Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 43. Rest of Latin America Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 44. Rest of Latin America Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 45. The Middle-East and Africa Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 46. The Middle-East and Africa Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 47. GCC Countries Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 48. GCC Countries Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 49. South Africa Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 50. South Africa Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)
  • 51. Rest of Middle-East Africa Ultrasonic Dissection Devices Market revenue, By Type, 2022 – 2030 (USD Million)
  • 52. Rest of Middle-East Africa Ultrasonic Dissection Devices Market revenue, By End User, 2022 – 2030 (USD Million)

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2030

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2028
  • Market revenue estimates and forecasts up to 2028, by technology
  • Market revenue estimates and forecasts up to 2028, by application
  • Market revenue estimates and forecasts up to 2028, by type
  • Market revenue estimates and forecasts up to 2028, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Key Players 

  • Grail, LLC (Illumina, Inc.)
  • Exact Sciences Corporation.
  • Foundation Medicine, Inc.
  • AnchorDx
  • Guardant Health, Inc.
  • Burning Rock Biotech Limited
  • GENECAST
  • Laboratory for Advanced Medicine, Inc.
  • Singlera Genomics Inc.

FAQs

The “Europe” region will lead the global Multi Cancer Early Detection market from 2022 to 2030.

The key factors driving the market are multi-cancer early detection in hospitals and laboratory sectors.

The key players operating in the Multi Cancer Early Detection market are Grail LLC (Illumina Inc.), Exact Sciences Corporation., Foundation Medicine Inc., AnchorDx, Guardant Healt Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine Inc., Singlera Genomics Inc.

The global Multi Cancer Early Detection market is expanding with a CAGR of approximately 16.5% during the forecast period (2022 to 2030)

The global Multi Cancer Early Detection market was valued at USD 800.23 million in 2021 and is projected to reach around USD 2.89 billion by 2030.

PURCHASE OPTIONS

excel
$

3200


pdf excel
$

4200


pdf excel powerbi
$

5200


excel
$

1800

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
View cart

Find it too expensive?
NO WORRIES!